This project will evaluate AppliedVR's EaseVRx - a multi-modal, skills-based, 8-week, virtual reality, home intervention - in an exploratory randomized controlled trial for self-management of chronic pain among Black, young adults (ages 18-50) with sickle cell disease.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Pain Rating Using Numerical Pain Rating Scale (NPRS)
Timeframe: Baseline, up to week 4 or time period 1 (day 1-28), from week 4 to 8 or time period 2 (days 29-56)
Pain Intensity Subscale of the Chronic Pain Grade Questionnaire
Timeframe: Baseline, week 4, week 8, and 4 weeks post-intervention (week 12)
Participant Engagement: Minutes of Program Use Per Day
Timeframe: up to week 4 or time period 1 (day 1-28), from week 4 to 8 or time period 2 (days 29-56)
Participant Engagement: Duration in Days
Timeframe: Baseline, daily during treatment (4 weeks or time period 1, day 1-28), daily during treatment (8 weeks or time period 2, days 29-56)
Participant Engagement: Features Utilized
Timeframe: Daily during treatment (8 weeks)
Participant Engagement: Completion Rates
Timeframe: Daily average during treatment (up to 8 weeks)
Study Retention: Surveys
Timeframe: Baseline, 4 weeks, 8 weeks and 4 weeks post-intervention (week 12)
Study Retention: Daily Diaries
Timeframe: Up to 8 weeks
Participant Satisfaction
Timeframe: Post-treatment (up to 6 weeks post-treatment)
Frequency of Highest Satisfaction Scores
Timeframe: Post-treatment (up to 6 weeks post-treatment)
Safety: Number of Adverse Events
Timeframe: 4 weeks, 8 weeks, up to 6 weeks post-treatment